Anemia, Sickle Cell: all 1,125 studies
Page 9 of 12. Open to participants first (238), then studies with results posted, then the rest; newest registration first within each.
- Dose-Finding Study of SC411 in Children With Sickle Cell DiseaseStatus unknownNCT02973360Phase 2
- Vitamin D and Bisphosphonates in the Treatment of Sickle Cell DiseaseCompletedNCT02972138
- Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell DiseaseWithdrawnNCT02960503Phase 1/2
- Neurovascular Determinants of Cognitive Function in Adults With Sickle Cell DiseaseCompletedNCT02946905
- Glucose Metabolism in Sickle Cell DiseaseActive, not recruitingNCT02922296
- Sickle Cell Anemia and Cerebral Microcirculation : Multimodal ExplorationCompletedNCT02909283
- Dense Red Blood Cells in Sickle Cell ChildrenTerminatedNCT02887118
- Study of Hydroxyurea to Treat Sickle Cell DiseaseCompletedNCT02868138
- Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell DiseaseCompletedNCT02867800Phase 1
- Feasibility and Efficacy of a Home-based, Computerized Cognitive Training Program in Pediatric Sickle Cell DiseaseCompletedNCT02857023Not applicable
- Mobile-Directly Observed Therapy on Adherence to HydroxyureaCompletedNCT02844673Phase 2
- STRIDE BiorepositoryStatus unknownNCT02843347
- Evaluation of Non-invasive Endothelial Function in Children Sickle by Vascular UltrasoundCompletedNCT02829580Not applicable
- Cerebrovascular Reserve Measurements in Sickle Cell DiseaseStatus unknownNCT02824406
- Oxygen Therapy and Pregnancy in Sickle Cell DiseaseCompletedNCT02813850Phase 3
- tDCS Associated With Peripheral Electrical Stimulation for Pain Control in Individuals With Sickle Cell DiseaseStatus unknownNCT02813629Phase 2
- Ketamine as an Adjuvant Therapy for Acute Vaso Occlusive Crisis in Pediatric Patients With Sickle Cell DiseaseStatus unknownNCT02801292Phase 3
- Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text MessagingCompletedNCT02785848
- HLA-Identical Sibling Donor Bone Marrow Transplantation for Individuals With Severe Sickle Cell Disease Using a Reduced Intensity Conditioning RegimenStatus unknownNCT02776202Phase 2
- Evaluating Thromboelastography (TEG) and ETP in Sickle AdultsCompletedNCT02770534
- SACRED A Prospective Research Study to Reduce Stroke in Children With Sickle Cell AnemiaCompletedNCT02769845Not applicable
- The Feasibility of the PAINReportIt Guided Relaxation Intervention-OutpatientCompletedNCT02729363Not applicable
- The Feasibility of the PAINReportIt Guided Relaxation Intervention-INPATIENTCompletedNCT02729350Not applicable
- Plasma DNA and Vascular Remodelling in Patients With Sickle Cell DiseaseCompletedNCT02721472Not applicable
- The Role of Endothelin-1 in Sickle Cell DiseaseCompletedNCT02712346Phase 1
- Hydroxyurea in the Treatment of Sickle Cell DiseaseCompletedNCT02709681
- A Comprehensive Care Plan for Pediatric Patients With Vaso-Occlusive CrisesTerminatedNCT02698761Not applicable
- Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell DiseaseTerminatedNCT02678143Phase 1
- Moderate Dose Hydroxyurea for Secondary Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan AfricaCompletedNCT02675790Phase 3
- A Study of SANGUINATE for the Treatment of Vaso-occlusive Crisis (VOC) in Adult Sickle Cell Disease PatientsCompletedNCT02672540Phase 2
- A Study of Oral L-citrulline in Sickle Cell DiseaseWithdrawnNCT02659644Phase 1
- Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell DiseaseTerminatedNCT02636387
- A Pilot Study of Azithromycin Prophylaxis for Acute Chest Syndrome in Sickle Cell DiseaseWithdrawnNCT02630394Phase 1
- A Brief Laboratory-Based Hypnosis Session for Pain in Sickle Cell DiseaseCompletedNCT02620488Not applicable
- Autologous Bone Marrow Stem Cells for Chronic Leg Ulcer Treatment in Sickle Cell DiseaseStatus unknownNCT02619734Phase 1
- Clinical Trial to Study the Safety and Tolerability of Memantin Mepha® in Sickle Cell Disease PatientsCompletedNCT02615847Phase 2
- Survey in a Population of Sickle Cell Disease Patients to Evaluate the Transition Between the Queen Fabiola Children Hospital and the CHU Brugmann Hospital, and the Quality of the Hospital Care Within the CHU Brugmann Hospital.CompletedNCT02608580Not applicable
- A Sickle CEll Disease ComplicatioN TrialStatus unknownNCT02604368Phase 3
- SANGUINATE™ in Sickle Cell Disease Associated Leg UlcerCompletedNCT02600390Phase 2
- Improving Quality by Maintaining Accurate Problems in the EHRCompletedNCT02596087Not applicable
- Contraception in Women With Sickle Cell DiseaseCompletedNCT02594462Phase 4
- Prevalence of Problematic Use of Equimolar Mixture of Oxygen and Nitrous Oxide and Analgesics in the Sickle-cell DiseaseCompletedNCT02580565
- ElectroNic Hydroxyurea AdhereNCE: A Strategy to Improve Hydroxyurea Adherence in Patients With Sickle Cell DiseaseCompletedNCT02578017Not applicable
- Sub-dissociative Intranasal Ketamine for Pediatric Sickle Cell Pain CrisesStatus unknownNCT02573714Not applicable
- Evaluation of a Training Program for Homozygous Sickle Cell Disease PatientsCompletedNCT02571088Not applicable
- A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy SubjectsCompletedNCT02567695Phase 1
- Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy SubjectsCompletedNCT02567682Phase 1
- Study of Ventilatory Mechanics in Patients With Sickle Cell AnemiaCompletedNCT02565849
- Evaluation of the Hemostatic Potential in Sickle Cell Disease PatientsCompletedNCT02565082Not applicable
- Comparison of Two Methods of Transfusion for Stroke Prevention in Sickle CellCompletedNCT02561312
- Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa IICompletedNCT02560935Phase 3
- EXTEND EXpanding Treatment for Existing Neurological DiseaseCompletedNCT02556099Phase 2
- Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal EventsCompletedNCT02539771Not applicable
- Prevention of Vaso-occlusive Painful Crisis by Using Omega-3 Fatty Acid SupplementsStatus unknownNCT02525107Phase 3
- Sevuparin Infusion for the Management of Acute VOC in Subjects With SCDCompletedNCT02515838Phase 2
- Web-MAP Intervention for Youth With Sickle Cell DiseaseCompletedNCT02511769Not applicable
- Feasibility of a Stress Reduction Intervention Study in Sickle Cell DiseaseCompletedNCT02501447Not applicable
- A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male SubjectsCompletedNCT02497924Phase 1
- SMART Mobile Application Technology Utilization in the Treatment of Sickle Cell Disease Post Day Hospital DischargeCompletedNCT02475993Not applicable
- Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell AnemiaCompletedNCT02467257Phase 1/2
- Evaluation of Repeat Administration of Purified Poloxamer 188CompletedNCT02449616Phase 3
- Autologous Bone Marrow Stem Cell Transplantation for Osteonecrosis in Sickle Cell DiseaseStatus unknownNCT02448121Phase 1/2
- Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell DiseaseCompletedNCT02447627
- Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell DiseaseTerminatedNCT02445144
- Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell DiseaseTerminatedNCT02433158Phase 3
- Ketamine Infusion for Acute Sickle Cell Crisis in the Emergency DepartmentTerminatedNCT02417298Not applicable
- Study of SANGUINATE™ In the Treatment of Sickle Cell Disease Patients With Vaso-Occlusive CrisisCompletedNCT02411708Phase 2
- Improving Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell DiseaseCompletedNCT02394899Not applicable
- MBSR for Pain Catastrophizing in SCDCompletedNCT02394587Not applicable
- Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell DiseaseCompletedNCT02394431
- Single-center Prospective Evaluation of Sickle Cell Patient Care in the CHU Brugmann Emergency DepartmentCompletedNCT02386657
- Cognitive Behavioral Therapy and Real-time Self-management Intervention for SCD Via Mobile ApplicationsCompletedNCT02384590Not applicable
- Dose-Escalation Study of SCD-101 in Sickle Cell DiseaseStatus unknownNCT02380079Phase 1
- Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell DiseaseCompletedNCT02371720Not applicable
- Sickle Cell Hemoglobinopathies and Bone HealthActive, not recruitingNCT02306993
- Therapeutic Response Evaluation and Adherence Trial (TREAT)Active, not recruitingNCT02286154Not applicable
- A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell DiseaseCompletedNCT02285088Phase 1
- Immunogenicity Study of an Anti-pneumococcal Vaccination Strategy in Patients With Sickle Cells DiseaseCompletedNCT02274415Phase 2
- A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell DiseaseCompletedNCT02261480
- Hepcidin Levels in Sickle Cell Disease (SCD)CompletedNCT02258997
- Stem Cell Gene Therapy for Sickle Cell DiseaseCompletedNCT02247843Phase 1/2
- QST-Pupillometry in Sickle Cell Disease PatientsCompletedNCT02242058
- Screening Patients With Sickle Cell Disease for Kidney DamageCompletedNCT02239016
- Working Memory and School Readiness in Preschool-Aged Children With Sickle Cell DiseaseCompletedNCT02227472
- Fertility Preservation in Women Who Will Have Gonadotoxic Therapy or Hematopoetic Stem Cell Transplantation, and in Women With Sickle Cell DiseaseCompletedNCT02225145
- Functional Neuroimaging of Pain Using EEG and fMRICompletedNCT02212691
- Assessment of Tolerance of Mobilizing Peripheral Hematopoietic Stem Cells by Plerixafor in Sickle Cell PatientsCompletedNCT02212535Phase 1/2
- Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient NavigatorsCompletedNCT02197845Not applicable
- Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell DiseaseCompletedNCT02193191Phase 1
- Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility TrialCompletedNCT02187445Phase 1
- Gene Transfer for Patients With Sickle Cell DiseaseTerminatedNCT02186418Phase 1/2
- Hematopoietic Stem Cell Transplant for High Risk HemoglobinopathiesTerminatedNCT02179359Not applicable
- Study of Beet Juice for Patients With Sickle Cell AnemiaWithdrawnNCT02162225Phase 2
- Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea TreatmentCompletedNCT02149537Phase 4
- Medication Adherence in Youth With Sickle Cell Disease (SCD)CompletedNCT02143076
- Use of Mobile Technology for Intensive Training in Medication ManagementCompletedNCT02133560Not applicable
- Risk-based Therapy for Sickle Cell Anemia: A Feasibility StudyWithdrawnNCT02090296Phase 2
- Hematopoietic Stem Cell Transplant for Sickle Cell DiseaseCompletedNCT02065596Phase 1
- Novel Dose Escalation to Predict Treatment With HydroxyureaCompletedNCT02042222Early Phase 1
- Allograft for Sickle Cell Disease and ThalassemiaWithdrawnNCT02038478Phase 2